FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

MANGALAM

138.8
+6.6 (4.99%)
Updated 11:12 01/10 IST

MANGALAM Buy or Sell - FrontPage Forums

2 Users have submitted 3 trade ideas of Rs. 504,350 for MANGALAM
Disclaimer
100% Bullish
0% Bearish

MANGALAM Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See MANGALAM Share Price Targets >>

MANGALAM Ratings

Long term MANGALAM rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live MANGALAM message board: Is MANGALAM buy or sell? Should I buy MANGALAM shares? Why are MANGALAM shares falling? Should I invest in MANGALAM stock?

  1. Home
  2. MANGALAM Forum

MANGALAM Share Price Discussion


Type
Buy
Instrument
MANGALAM
Entry Price
₹144
Price@Trade
₹144.1
Target Price
₹190
Stop Price
₹110
Valid Till
Sep 17, 2021 3:20 AM
Margin
₹864,000 approx for 6000 Qty
Status
Waiting for entry
Like
Reply
M
Reputation: 9,192 • Sep 18 8:54 AM

Type
Buy
Instrument
NIFTY 24SEP20 11450 PE
Entry Price
₹65  ₹66.15
Price@Trade
₹68.3
Target Price
₹95
Stop Price
₹50
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹496,125 approx for 7500 Qty
Status
Waiting for entry
Like
Reply (3)
See all replies
Mrc The Boss @Mrc
Sep 18 8:54 AM

Update
Entry Price Modified
Price @ Update
₹68.35
Original Entry Price
₹65
New Entry Price
₹68.35
Mrc The Boss @Mrc
Sep 18 8:54 AM

Update
Entry Price Modified
Price @ Update
₹66.7
Original Entry Price
₹68.35
New Entry Price
₹66.7
Mrc The Boss @Mrc
Sep 18 8:54 AM

Update
Entry Price Modified
Price @ Update
₹66.15
Original Entry Price
₹66.7
New Entry Price
₹66.15
J
Reputation: -1,498 • Sep 18 8:54 AM

Type
Buy
Instrument
BANKNIFTY 24SEP20 22200 CE
Entry Price
₹296.95
Price@Trade
₹296.95
Target Price
₹320
Stop Price
₹280
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹148,475 approx for 500 Qty
Status
Active
Like
Reply
R
Reputation: -6,226 • Sep 18 8:53 AM

Type
Buy
Instrument
NIFTY 24SEP20 11500 CE
Entry Price
₹103.6
Price@Trade
₹103.6
Target Price
₹120
Stop Price
₹100
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹777,000 approx for 7500 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
BANKNIFTY 24SEP20 21900 PE
Entry Price
₹271
Price@Trade
₹271.7
Target Price
₹320
Stop Price
₹260
Valid Till
Sep 21, 2020 3:20 AM
Margin
₹677,500 approx for 2500 Qty
Status
Active
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Sep 18 8:54 AM

Update
Trade Entered
Entry Price
₹271
J
Reputation: -1,498 • Sep 18 8:53 AM

Type
Buy
Instrument
BANKNIFTY 24SEP20 22000 PE
Entry Price
₹313.25
Price@Trade
₹313.25
Target Price
₹380
Stop Price
₹280
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹78,312.5 approx for 250 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
IOLCP
Entry Price
₹828.55
Price@Trade
₹828.55
Target Price
₹1,000
Stop Price
₹700
Valid Till
Sep 17, 2021 3:20 AM
Margin
₹82,855 approx for 100 Qty
Status
Active
Like
Reply
K
Reputation: -33,288 • Sep 18 8:52 AM
King999 in JUBLFOOD
Look at this chart price making highs but now ...
Like
Reply
R
Reputation: -6,226 • Sep 18 8:52 AM

Type
Buy
Instrument
NIFTY 24SEP20 11500 PE
Entry Price
₹86.35
Price@Trade
₹86.35
Target Price
₹120
Stop Price
₹80
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹647,625 approx for 7500 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
HESTERBIO
Entry Price
₹1,752.65
Price@Trade
₹1,752.65
Target Price
₹1,900
Stop Price
₹1,650
Valid Till
Sep 17, 2021 3:20 AM
Margin
₹87,632.5 approx for 50 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
BANKNIFTY 24SEP20 FUT
Entry Price
₹22,060
Price@Trade
₹22,060
Target Price
₹22,300
Stop Price
₹21,900
Valid Till
Sep 21, 2020 3:20 AM
Margin
₹489,572 approx for 100 Qty
Status
Active
Like
Reply
J
Reputation: 3,823 • Sep 18 8:52 AM

Type
Buy
Instrument
NATURALGAS 25SEP20 FUT
Entry Price
₹147.5
Price@Trade
₹147.9
Target Price
₹152
Stop Price
₹145.5
Valid Till
Sep 18, 2020 11:20 AM
Margin
₹971,218.75 approx for 25000 Qty
Status
Waiting for entry
Like
Reply
J
Reputation: -1,498 • Sep 18 8:52 AM

Type
Buy
Instrument
BANKNIFTY 24SEP20 21800 PE
Entry Price
₹242.05
Price@Trade
₹242.05
Target Price
₹290
Stop Price
₹220
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹60,512.5 approx for 250 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
NATCOPHARM
Entry Price
₹885.8
Price@Trade
₹885.8
Target Price
₹1,000
Stop Price
₹800
Valid Till
Oct 16, 2020 3:20 AM
Margin
₹88,580 approx for 100 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
BANKNIFTY 24SEP20 21900 PE
Entry Price
₹280
Price@Trade
₹283.75
Target Price
₹320
Stop Price
₹270
Valid Till
Sep 21, 2020 3:20 AM
Margin
₹700,000 approx for 2500 Qty
Status
Exited before entry
Like
Reply (3)
See all replies

Update
Entry Price Modified
Price @ Update
₹281.35
Original Entry Price
₹280
New Entry Price
285.0

Update
Entry Price Modified
Price @ Update
₹274.65
Original Entry Price
₹285
New Entry Price
280.0

Update
Exited before entry
Price @ Update
₹273.85

Type
Buy
Instrument
JUBLFOOD SEP20 2350 CE
Entry Price
₹57
Price@Trade
₹57
Target Price
₹80
Stop Price
₹40
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹28,500 approx for 500 Qty
Status
Active
Like
Reply
N
Reputation: 6,008 • Sep 18 8:51 AM
Banks cannot auction project without the approval of buyers, authority: Haryana RERA
Gurgaon bench of Haryana Real Estate Regulatory Authority has threatened to take penal action against the banks if they auction the project of any builder to recover dues, without taking the approval of the authority.
The Economic Times
Like
Reply

Type
Sell
Instrument
NATURALGAS 25SEP20 FUT
Entry Price
₹148.2
Price@Trade
₹147.9
Target Price
₹135
Stop Price
₹160
Valid Till
Sep 25, 2020 11:20 AM
Margin
₹242,796.88 approx for 6250 Qty
Status
Active
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Sep 18 8:51 AM

Update
Trade Entered
Entry Price
₹148.2

Type
Buy
Instrument
PNB NOV20 FUT
Entry Price
₹32.7
Price@Trade
₹32.7
Target Price
₹35.5
Stop Price
₹30
Valid Till
Nov 26, 2020 3:20 AM
Margin
₹198,989 approx for 14000 Qty
Status
Active
Like
Reply
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • MANGALAM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization87.3
    Enterprise Value144.98
    Price to Earnings12.9
    Price to Book Value0.91
    Return on Capital Employed0.24
    Return on Equity0.19
    Face Value10
    Dividend YieldNA
  • MANGALAM - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    19-Apr-17ICICIdirect.comBuy230
    MANGALAM Brokerage Price Target
  • MANGALAM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 30134134.5131132.2
    Sep 29138.65138.65133134.35
    Sep 28140.8140.8132.4135.95
    Sep 25132.6137.7132.6135.3
    Sep 24137137131.5132
  • MANGALAM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹136.31
    30 Day Moving Average₹138.54
    50 Day Moving Average₹95.65
    100 Day Moving Average₹63.32
    200 Day Moving Average₹47.05
  • MANGALAM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue279.38302.89-0.08
    Operating Profit46.8748.16-0.03
    Profit Before Tax29.3533.38-0.12
    Net Income19.8923.7-0.16
  • MANGALAM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds95.76105.18-0.09
    Total Liabilities113.37132.43-0.14
    Total Assets209.13237.61-0.12
  • MANGALAM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity24.5842.29-0.42
    Cash from Investing Activity-15.95-39.45-0.6
    Cash from Financing Activity-8.82-2.712.25
    Net Cash Flow-0.20.13-2.54
  • MANGALAM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.080.12
    Return on Equity0.190.28
    Return on Capital Employed0.240.28
  • MANGALAM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.27
    3 Year CAGR Growth in Operating Profit1.31
    3 Year CAGR Growth in EBIDTA1.33
    3 Year CAGR Growth in Net Income2.24
    3 Yr CAGR Growth - Diluted EPS1.68
  • MANGALAM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.23
    5 Year CAGR Growth in Operating Profit11.63
    5 Year CAGR Growth in EBIDTA17.8
    5 Year CAGR Growth in Net Income2.69
    3 Yr CAGR Growth - Diluted EPS2.4
  • MANGALAM - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 25 3:51 AM
    Share market update: 94 stocks hit 52-week highs on NSE
    The Economic Times
    NewsBot
    Aug 11 11:03 AM
    Mangalam Drugs Standalone June 2020 Net Sales at Rs 103.64 crore, up 59.34% Y-o-Y
    Moneycontrol
    NewsBot
    Jul 1 5:13 AM
    Mangalam Drugs Standalone March 2020 Net Sales at Rs 88.09 crore, up 83.19% Y-o-Y
    Moneycontrol
    NewsBot
    Apr 10 1:18 AM
    India has enough HCQ capacity to serve demand, clinical trial outcome is crucial
    Moneycontrol
    NewsBot
    Jan 28 6:13 AM
    Mangalam Drugs Standalone December 2019 Net Sales at Rs 61.94 crore, up 27.5% Y-o-Y
    Moneycontrol
    NewsBot
    Jul 29, 2019 6:38 AM
    Mangalam Drugs Standalone June 2019 Net Sales at Rs 65.04 crore, up 10.23% Y-o-Y
    moneycontrol.com
    NewsBot
    Jul 15, 2019 3:48 AM
    NewsBot
    Feb 12, 2019 6:42 AM
    NewsBot
    Feb 12, 2019 1:42 AM
    NewsBot
    Dec 10, 2018 3:12 AM
  • MANGALAM - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020